Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center
- 29 August 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (S2), 483-484
- https://doi.org/10.1007/s10072-020-04667-0
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central ItalyThe Journal of Headache and Pain, 2020
- Erenumab: from scientific evidence to clinical practice—the first Italian real-life dataNeurological Sciences, 2019
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionThe Journal of Headache and Pain, 2019